Calabasas, Calif., March 10, 2014 – KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced it will release its fourth quarter and full year 2013 operating results and will host an investor call and webcast at 4:30 p.m. ET on Monday, March 17, 2014.
Individuals interested in participating in the call should dial (877) 344-3890 (U.S. and Canada) or (760) 666-3770 (international) using conference ID number 11337705. To access the webcast, please visit the Investors section of KYTHERA's website at www.kytherabiopharma.com.
The call will be available for replay via telephone starting March 17, 2014, at approximately 5:30 p.m. ET, running through 11:59 p.m. ET on March 24, 2014. To listen to the replay, dial (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international) using conference ID number 11337705. The archived webcast will be available on KYTHERA's website for seven days beginning approximately one hour after the call has completed.
About KYTHERA Biopharmaceuticals, Inc.
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA’s product candidate, ATX-101, is currently in late stage clinical development for the reduction of submental fat, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring.